Real World Evidence en pacientes pediátricos con Enfermedad de Crohn activa. Estudio REVIDEC.

Datos básicos

Código:
Estudio REVIDEC
Protocolo:
Estudio REVIDEC
EUDRACT:
NCT:
Centro:
HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Dotación:
Año de incio:
2023
Año de finalización:
PI BIOMÉDICA

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

OUTCOMES 10 SLU

Resultados del Ensayo Clínico


"Geographical distribution of risk genotypes in pediatric patients with celiac disease in Spain".

Sanchez-Valverde, Felix; (...); Roman, Enriqueta

Article. 10.1016/j.humimm.2023.01.010. 2023


Coeliac Disease Case-Control Study: Has the Time Come to Explore beyond Patients at Risk?

Castillejo, Gemma; (...); Roman, Enriqueta

Article. 10.3390/nu15051267. 2023

  • Open Access.

Effect of beta-glucan supplementation on cystic fibrosis colonic microbiota: an in vitro study.

Asensio-Grau, Andrea; (...); Calvo-Lerma, Joaquim

Article. 10.1038/s41390-023-02944-0. 2023


Exploring histological remission in pediatric patients with celiac disease.

Marset, Gema; (...); Donat, Ester

Article. 10.17235/reed.2024.10697/2024. 2024

  • Open Access.

Faecal lipid profile as a new marker of fat maldigestion, malabsorption and microbiota.

Asensio-Grau, Andrea; (...); Calvo-Lerma, Joaquim

Article. 10.1038/s41390-024-03209-0. 2024


IMPACT-III and IMPACT-III-P questionnaires: the transcultural adaptation and validation in Spanish families. A SEGHNP (Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition) multicenter study

Rodriguez-Belvis, M. Velasco; (...); Martin de Carpi, J.

Meeting Abstract. 2024

  • Open Access.

Long-term evaluation of faecal calprotectin levels in a European cohort of children with cystic fibrosis.

Roca M; (...); Calvo-Lerma J

Article. 10.1136/archdischild-2023-326221. 2023

  • Open Access.

Rational application of the ESPGHAN 2022 recommendations for the follow up of the paediatric coeliac patient: consensus document of scientific societies (SEGHNP, AEPap, SEPEAP, SEEC, AEG, SEPD, SEMFYC, SEMG and SEMERGEN)

Roman, Enriqueta; (...); Soci Atencion Primaria Adultos SEMFYC SEMG SEMERGEN

Article. 10.1016/j.anpedi.2024.09.001. 2024

  • Open Access.

Rational application of the ESPGHAN 2022 recommendations for the follow-up of the paediatric coeliac patient: consensus document of scientific societies (SEGHNP, AEPAP, SEPEAP, SEEC, AEG, SEPD, SEMFYC, SEMG and SEMERGEN).

Roman E; (...); Donat YE

Article. 10.1016/j.anpede.2024.09.008. 2024

  • Open Access.

Study of the immune response in celiac patients with selective IgA deficiency who start a gluten-free diet.

Giner-Perez, Lola; (...); Roca, Maria

Article. 10.1007/s10238-023-01040-1. 2023

  • Open Access.

Transcultural adaptation and validation of IMPACT-III and IMPACT-III-P in Spanish families: a multicenter study from SEGHNP.

Velasco Rodriguez-Belvis, Marta; (...); Andres Esteban, Eva Maria

Article. 10.1007/s00431-024-05575-7. 2024

  • Open Access.

Campos de estudio

Compartir